iifl-logo

Shukra Pharmaceuticals Ltd Cash Flow Statement

12.35
(-5.00%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shukra Pharma. FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Profit before tax

0.06

0.72

0.94

1.05

Depreciation

-1.47

-0.96

-0.73

-0.46

Tax paid

-0.13

-0.26

-0.42

-0.55

Working capital

0.39

1.47

0.26

0.19

Other operating items

Operating

-1.15

0.96

0.05

0.23

Capital expenditure

3.23

2.45

4.68

0.96

Free cash flow

2.07

3.41

4.73

1.2

Equity raised

27.62

26.78

25.92

25.09

Investing

0

0

0.01

0

Financing

14.11

9.64

3.62

0.08

Dividends paid

0

0

0

0.07

Net in cash

43.81

39.84

34.28

26.46

Shukra Pharma. : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.